Results 91 to 100 of about 33,059 (231)
Transcatheter aortic valve implantation [PDF]
Ariel Finkelstein+2 more
openaire +6 more sources
Frequency of and Prognostic Significance of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation [PDF]
The prognostic implications of preexisting atrial fibrillation (AF) and new-onset AF (NOAF) in transcatheter aortic valve implantation (TAVI) remain uncertain.
Brown, D. L.+9 more
core +1 more source
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye+19 more
wiley +1 more source
Autopsy after transcatheter aortic valve implantation [PDF]
Autopsy after transcatheter aortic valve implantation (TAVI) is a new field of interest in cardiovascular pathology. To identify the cause of death, it is important to be familiar with specific findings related to the time interval between the procedure and death.
van Kesteren, F+13 more
openaire +5 more sources
Cost effectiveness of aortic valve therapies: a systematic review of the literature
Background: we performed a systematic review on the cost effectiveness of transcatheter aortic valve implantation (TAVI) to standard aortic valve replacement and medical management in high-risk elderly patients with severe aortic stenosis.Methods: in ...
Suzanne Battaglia+2 more
doaj +1 more source
3D printing is a transformative technology in congenital heart disease [PDF]
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child.
Anwar+117 more
core +3 more sources
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya+9 more
wiley +1 more source
Neurological Complications after Transcatheter Aortic Valve Implantation Procedure
Aortic stenosis is the most common primary valvular heart disease in both Europe and North America. In patients with symptomatic severe aortic stenosis, early surgical treatment is recommended because of the very poor prognosis and the lack of effect of ...
Daniel Rogowicz+7 more
doaj +1 more source
SOURCE 3 Registry Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve [PDF]
BACKGROUND: The SOURCE 3 Registry (SAPIEN Aortic Bioprosthesis European Outcome) is a European multicenter, observational registry of the latest generation of transcatheter heart valve, the SAPIEN 3 (Edwards Lifesciences, Irvine, CA).
Baumgartner, Helmut+9 more
core +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo+7 more
wiley +1 more source